As official media partners, VJHemOnc is thrilled to present updates from the 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT).
This year's meeting shed light on the latest research and education in hematological transplantation and cellular therapies.
We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies: 🎥: http://ow.ly/GGiK50KVRjM #MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022
We had a great interview with Catherine Coombs of @UNC, who shared some insights into novel BTK inhibitors in CLL and future outlooks. @SocietyofHemOnc #SOHO22 #HemOnc #LeuSM #CLLsm
Great discussion today, thanks Jorge, see you in Mandelieu for ESH CML meeting https://twitter.com/vjhemonc/status/1575582501913100288
A great session we had here today at #SOHO22 with CML experts Jorge Cortes (@GCC_Cortes) & Mhairi Copland (@CoplandMhairi)! Stay tuned for more of our expert-led discussions! @SocietyofHemOnc #SOHO2022 #HemOnc #LeuSM #CMLsm
#SOHO22 | Peter Valk (@ErasmusMC) discusses TP53-mutated AML and MDS, the prognostic value of FLT3-ITD residual disease in AML, and more. Visit http://VJHemOnc.com for our interviews from this year's meeting! #SOHO2022 #HemOnc #LeuSM #AMLsm #MDSsm
At #SOHO22: Our Dr. Robert Orlowski discusses early data in bispecific T cell engagement for treatment of multiple myeloma. @Myeloma_Doc #EndCancer
Explore all the practice-changing transplant updates presented at EBMT 2020 including conditioning, relapse risk factors and the impact of the microbiome!
CAR-T & Cellular Therapy
CAR-T has rapidly entered the treatment landscape of a vast number of hematological malignancies. Get the latest here!
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter